Pactiv Evergreen Announces Expiration Of HSR Act Waiting Period For Acquisition By Novolex At $18/Share, Expected To Close In Q2 2025; Will Become Private, Nasdaq Delisting Expected Upon Transaction Completion

Delist

Pactiv Evergreen

PTVE

0.00

Pactiv Evergreen Inc. ("Pactiv Evergreen" or the "Company") (NASDAQ:PTVE) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in connection with the Company's previously announced definitive agreement to be acquired by Novolex® for $18.00 per share in cash.

The transaction is expected to close in the second quarter of 2025, subject to receipt of foreign antitrust approvals and satisfaction of other customary closing conditions. Upon the completion of the transaction, Pactiv Evergreen will become a privately held company, and its common stock will no longer be listed on Nasdaq.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.